bf/NASDAQ:ARWR_icon.jpeg

NASDAQ:ARWR

Arrowhead Pharmaceuticals, Inc.

  • Stock

USD

Last Close

28.70

28/03 19:29

Market Cap

3.52B

Beta: 1.01

Volume Today

274.74K

Avg: 1.11M

PE Ratio

−16.68

PFCF: −12.05

  • industry

    Biotechnology
  • exchange

    NASDAQ Global Select
  • website

    arrowheadpharma.com
  • ipo date

    Dec 14, 1993
  • full time employees

    397
  • currency

    USD

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated wi...Show More

Earnings

Earnings per Share (Estimate*)

-1-0.50.512017-05-032018-12-112020-08-052022-02-022023-11-29

Revenue (Estimate*)

200M400M600M800M1B2017-05-032018-12-112020-08-052022-02-022023-11-29

*Estimate based on analyst consensus

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.